Explore BioBoost LabsOxytocin
Oxytocin is a nine-amino-acid cyclic peptide hormone and the first peptide hormone to have its structure confirmed by chemical synthesis.
What the name means
The name comes from Greek roots meaning “swift birth.”
Oxytocin was named for its observed effect on uterine contraction. The name is descriptive of an early-recognized biological action rather than a chemical code, so there is no abbreviation or number to decode here.
What it actually is
Oxytocin is a small cyclic peptide — nine amino acids, closed into a ring by a single disulfide bond.
LENGTH: 9 amino acids (a nonapeptide)
BONDS: peptide bonds plus one disulfide bond (Cys1-Cys6); C-terminus amidated
TYPE: cyclic peptide hormone
ORIGIN: native hormone, made in the hypothalamus
The established sequence is Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2. The two cysteines are joined by a disulfide bridge, forming a six-residue ring with a three-residue tail — a defining structural feature it shares with the closely related hormone vasopressin.
Where it came from
Oxytocin holds a landmark place in the history of peptide chemistry.
It is a natural mammalian hormone produced in the hypothalamus and released from the posterior pituitary. Its lasting scientific fame is due to Vincent du Vigneaud, who determined its sequence and, in the early 1950s, confirmed that structure by chemically synthesizing the active peptide — work recognized with the 1955 Nobel Prize in Chemistry. It is widely described as the first polypeptide hormone to be synthesized.
Why it was created — the thought process
Oxytocin was not designed; the achievement was proving its structure by rebuilding it.
At the time, showing that a proposed amino-acid sequence was correct meant synthesizing the molecule and demonstrating that the synthetic version behaved like the natural hormone. Oxytocin, being short, was a tractable and historically pivotal target — its synthesis established that peptide hormones could be made from scratch and their structures verified.
How it is made
As a genuine short peptide, oxytocin is made by peptide synthesis and then oxidatively cyclized.
Modern production assembles the nine-residue chain by solid-phase peptide synthesis, then forms the disulfide bond between the two cysteines to close the ring, followed by cleavage, deprotection and purification (typically HPLC) with mass-spectrometry confirmation. The disulfide-forming step is essential — without the ring, the molecule is not the native structure.
What the research actually shows — honestly
Oxytocin is one of the most thoroughly studied peptide hormones, but here it is presented only as reference science.
There is a large, decades-deep peer-reviewed literature on oxytocin’s physiology. That body of work does not constitute a use recommendation on this page: the content is research-use-only, is not medical advice, and specifies no dose or protocol. Human-use questions belong with a qualified clinician.
Selected research & sources
The items below are drawn from the peer-reviewed literature (PubMed) and describe results observed in research models or reported in the clinical literature. They are listed so the evidence can be examined at its source — not to suggest any use.
- Sikich L, et al. N Engl J Med. 2021. “Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.” doi.org/10.1056/NEJMoa2103583
Regulatory status: The obstetric injectable (Pitocin) is FDA-approved; the social-behavior/intranasal use is not approved, and RUO research material is not the approved drug. Research material, RUO.
◆ A reference, not a recommendation
This page explains what Oxytocin is and where it came from — the science and the story — not who should use anything, or how. These are research materials for laboratory research only; nothing here is medical, dosing, or treatment advice.
Research-use-only educational content. Factual overview; claims of clinical benefit are not implied.